OVARIAN CANCER

One, paclitaxel and cisplatin in the treatment of advanced ovarian cancer care <BR> <BR> 1990s Taxol is more of the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.

One, information and Methods

Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, confidence, days, diet, dose, drug, drugs, eat, ert, estrogen, family, fat, gene, group, growth, incidence, infusion, injection, intravenous, life, mass, metastasis, method, ovarian, paclitaxel, pain, patients, physical, poor, positive, psychological, quality, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, women

I. Overview

With the aging of the global trend of development, improve the economic status of women, more and more women start hormone replacement therapy (Hormone Replacement Therapy, HRT), to improve access to after menopause due to the decrease in the level of sex hormones related to various diseases. Clear evidence that: postmenopausal women with age, the incidence of coronary heart disease increased by about four times the fracture due to osteoporosis by 20%, died of complications due to pelvic fracture rate of 30%, after the 65-year-old Alzheimer's incidence rate increase every year <BR> and Application HRT can peer groups coronary heart disease risk 50% Alzheimer's risk reduced three times, especially worth mentioning is significantly reduced the incidence of rectal cancer. Long-term use of HRT cancer risk reduced year by year. HRT can also greatly improve the menopause, postmenopausal women with disease or ovarian surgery, radiotherapy in patients with a series of artificial menopause syndrome.

Tags: age, benign, blood, body, brca1, breast, cancer, carcinoma, care, cases, cause, cell, cells, clinical, cyst, cystic, diagnosis, diet, drug, early, eat, ert, estrogen, family, fat, gene, grams, group, groups, growth, gynecological, history, hrt, incidence, increased, injection, intravenous, life, lymph, malignant, metastasis, method, mutation, node, ovarian, patients, pelvic, positive, protein, quality, radiotherapy, rate, reduce, residual, risk, screening, second, study, surgery, surgical, survival, syndrome, therapy, time, treatment, tumor, tumors, usually, uterine, women

Cytoreductive surgery in the treatment of ovarian cancer Comprehensive Application and prospects

Foreign Medical Obstetrics and Gynecology volumes in 1999 Vol 26 No. 2

Tianjin Medical University General Hospital of Obstetrics and Gynecology (300,052) of the new QU (Summary) if Mi (revision)

Abstract <BR> since the 1980s, complete cytoreductive surgery to cisplatin-based combination chemotherapy for ovarian cancer as a conventional model, cytoreductive surgery is the complete impact of the prognosis of patients with one of the important factors for recurrent ovarian cancer once again cytoreductive surgery still some value , but to improve the survival rate of patients is more important to be effective after chemotherapy treatment as a necessary complement. Early ovarian cancer retroperitoneal lymph node dissection is reasonable and significance of the still controversial.

Tags: abdominal, age, annex, anti, bleeding, blood, cancer, cases, cause, cell, cells, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, early, eat, ert, exploration, gene, growth, incidence, increased, intraperitoneal, intravenous, life, lymph, malignant, metastasis, metastatic, method, mutation, node, ovarian, p53, patients, pelvic, physical, poor, positive, prognosis, quality, rate, reduce, resection, residual, response, second, staging, study, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors

Ovarian cancer is common gynecologic cancer, female genital tumors about 1 / 3. Can occur at any age, and women with reproductive seen. The incidence of ovarian cancer is women's genital cancer Habitat third place, as early diagnosis difficult, often found at the already advanced, but the mortality rate for the first gynecologic malignancies.
[Diagnosis]

A Symptoms

(1) abdominal discomfort or medium sized benign tumor rapid growth often cause bloating and discomfort.

(2) abdominal mass benign swelling growth slow, difficult to be discovered, patients are often inadvertently touched. Malignant tumors grow fast, easily detected.

Tags: abdominal, age, anti, benign, bleeding, blood, cancer, carcinoma, cause, cell, cells, cyst, cystic, diagnosis, early, eat, ert, estrogen, examination, gene, growth, incidence, increased, lymph, malignant, mass, metastasis, metastatic, node, oppression, ovarian, ovary, pain, patients, pelvic, positive, rate, reduce, surface, symptoms, tumor, tumors, uterine, women

[Summary]

Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus, which ranked third. But ovarian cancer death, accounts of the first gynecologic tumors, right pose a serious threat to women's lives. Because ovarian embryonic development, organization anatomy and endocrine function more complicated, it may be suffering from benign tumors or malignant. Because of early ovarian cancer in asymptomatic, and the identification of its type benign and malignant very difficult, ovarian carcinoma laparotomy in ovarian tumor confined to only 30%, most have spread to the uterus, bilateral annex, the omentum and pelvic organs, both in the diagnosis of ovarian cancer and governance the treatment is a major problem indeed. Over the years experts on the pathological form of ovarian cancer, the development of clinical and treatment programs for many of accumulated a lot of experience, so far, statistics on domestic and foreign clinical data, the five-year survival rate of only 25% to 30%.

Tags: abdominal, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, care, cases, cause, cell, cells, chemotherapy, clinical, cyst, cystic, days, diagnosis, dose, drug, drugs, early, eat, ert, estrogen, examination, exploration, gene, grams, growth, gynecological, history, incidence, increased, injection, intraperitoneal, intravenous, irradiation, life, lymph, malignant, mass, metastasis, method, node, oppression, ovarian, ovary, pain, patients, pelvic, poor, prognosis, protein, radiation, radiotherapy, rate, reduce, resection, residual, screening, staging, surface, surgery, surgical, survival, symptoms, syndrome, therapy, time, toxicity, treatment, tumor, tumors, uterine, women

Ovarian cancer
	Ovarian cancer is a malignancy in ovarian tissue. Clinically, there will be abdominal discomfort, abdominal pain, abdominal mass, menstrual disorders, oppression and other symptoms. Ovarian cancer onset conceal, not found early, easy transfer characteristics of poor prognosis. Of all gynecologic malignancies around 15%. The incidence of ovarian cancer in common malignancy in women as a percentage of 2.4-5.6%. In the female reproductive tract malignancies in the third place, behind cervical and uterine corpus cancer. In women's reproductive tract cancers, ovarian cancer is the highest cause of death of a tumor. Ovarian cancer can occur at any age. Ovarian cancer belong to the medicine "of Zheng Jia", "build up" areas.

Tags: abdominal, age, body, cancer, cause, cell, cells, clinical, early, eat, incidence, mass, oppression, ovarian, pain, poor, prognosis, symptoms, tumor, uterine, women

Ovarian cancer is a common cancer of female genital mutilation one of the incidence of cervical cancer and after cancer of the uterus. Ovarian cancer incidence rate of 1.8% in early ovarian cancer prognosis good, and Phase III ovarian cancer prognosis after the five-year survival rate is about 15% but more than 70% of patients at diagnosis is already late, so who died from ovarian cancer for the first of Gynecologic Oncology [1 ]. The definition of terminal care: treatment without significance that foresee only survived six months which is death [2]. In China, no time limit and dying. In general, patients in the active treatment no hope to survive until the end of this period of life known as the terminal phase, which is the period dying nursing care. At this point control pain and symptomatic treatment, so that patients have the best quality of life is necessary and important. For nearly two years, in Section I of ovarian cancer patients with terminal care process, the active use of comfortable nursing theory, the patients through the psychological care, nutritional support, skin care, cancer care, patients and family members have been authorized satisfactory results.

Tags: cancer, care, diagnosis, early, eat, family, gene, incidence, life, ovarian, pain, patients, prognosis, psychological, quality, rate, skin, survival, time, treatment

Abstract: Application of transvaginal ultrasound contrast with early ovarian cancer screening with a simple standard, the advantages of the Express. (Cancer 2000; 89:582-587)

According to the Japanese study published in the August 1 published in the Journal of Cancer Cancer), a research report said they Application of transvaginal ultrasound contrast (transvaginal EUS.Silver, TVS) screening early ovarian cancer. Hirosaki University School of Medicine, Dr. Sato and his colleagues at TVS to 183,034 cases of asymptomatic women for as long as 10 follow-up inspection. These patients have participated in cervical cancer screenings, and just completed a two-minute inspection. In these women, 51,550 women were screened for the first time the census.

Tags: age, cancer, carcinoma, cases, cause, early, eat, incidence, metastasis, method, ovarian, patients, positive, screening, second, study, surgery, time, treatment, tumor, women

Breast cancer screening time <BR> <BR> that breast cancer screening, women will think about breast self-examination. To promote breast self-examination has some significance to the advancement of women on the importance of breast health. But if not taught women how to correctly implemented, it is very dangerous. The American Cancer Medicine will not touch themselves, worries that if women should consult their doctors. Many studies have found that women can correct implementation of breast self-examination rate is not high, the United States is only about 32%.

Tags: abdominal, age, blood, body, breast, cancer, cause, cell, clinical, days, diagnosis, early, eat, ert, examination, family, gene, history, incidence, increased, life, lymph, metastasis, method, node, ovarian, pain, patients, rate, risk, screening, second, study, survival, time, treatment, tumor, tumors, usually, women

Currently, the incidence rates of ovarian cancer accounts for gynecologic malignancy in 23% ~ 27% as the world's five largest high cancer mortality leapt gynecologic tumors in the first place. It can happen to women of any age, but occurred in the before and after menopause, about half occurred after the age of 65.

Tags: administration, age, body, cancer, cause, cell, cells, chemotherapy, clinical, diagnosis, drug, early, eat, ert, examination, gene, gynecological, incidence, intraperitoneal, life, metastasis, method, ovarian, patients, pelvic, quality, radiotherapy, rate, resection, residual, surgery, surgical, survival, symptoms, therapy, time, treatment, tumor, tumors, women